Trametinib is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat melanoma. It is also being studied in the treatment of other types of cancers, including multiple myeloma.

SparkCures ID 50
Developed By GlaxoSmithKline
Generic Name Trametinib
Additional Names Mekinist, GSK11202
Treatment Classifications
  • MEK Inhibitor

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)


There are no resources, links or videos to display for this treatment.